Davelizomib

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C21H26BF2N3O7
Molecular Weight	481.255
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCN1C2=C(F)C=C(F)C=C2)B3O[C@@H](CC(O)=O)C(=O)O3

InChI

InChIKey=BMSAGHWUHGTMIV-ULQDDVLXSA-N

InChI=1S/C21H26BF2N3O7/c1-11(2)7-17(22-33-16(9-19(29)30)21(32)34-22)26-18(28)10-25-20(31)15-5-6-27(15)14-4-3-12(23)8-13(14)24/h3-4,8,11,15-17H,5-7,9-10H2,1-2H3,(H,25,31)(H,26,28)(H,29,30)/t15-,16-,17-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C21H26BF2N3O7
Molecular Weight	481.255
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	3 / 3
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 20:11:58 UTC 2023` Edited by `admin` on `Sat Dec 16 20:11:58 UTC 2023`
Record UNII	T3LN9U6BRF
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Davelizomib

Official Name

English

1,3,2-Dioxaborolane-4-acetic acid, 2-[(1R)-1-[[2-[[[(2S)-1-(2,4-difluorophenyl)-2-azetidinyl]carbonyl]amino]acetyl]amino]-3-methylbutyl]-5-oxo-, (4S)-

Common Name

English

davelizomib [INN]

Common Name

English

Code System Code Type Description

INN

12698

Created by admin on Sat Dec 16 20:11:58 UTC 2023 , Edited by admin on Sat Dec 16 20:11:58 UTC 2023

PRIMARY

FDA UNII

T3LN9U6BRF

Created by admin on Sat Dec 16 20:11:58 UTC 2023 , Edited by admin on Sat Dec 16 20:11:58 UTC 2023

PRIMARY

PUBCHEM

147112102

Created by admin on Sat Dec 16 20:11:58 UTC 2023 , Edited by admin on Sat Dec 16 20:11:58 UTC 2023

PRIMARY

CAS

2409841-51-4

Created by admin on Sat Dec 16 20:11:58 UTC 2023 , Edited by admin on Sat Dec 16 20:11:58 UTC 2023

PRIMARY

Related Record Type Details


					T3LN9U6BRF

Davelizomib

ACTIVE MOIETY

Comments:

proteasome inhibitor

Amount: